Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2002-02-15
2010-11-23
Krass, Frederick (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
Reexamination Certificate
active
07838565
ABSTRACT:
A preventive and/or therapeutic agent for diabetes complications, which comprises as an effective ingredient a cyclohexenone long-chain alcoholic derivative represented by the following formula (1): wherein, R1, R2and R3each independently represents a hydrogen atom or a methyl group and X represents a linear or branched C10-28alkylene or alkenylene group. The cyclohexenone long-chain alcoholic derivative of the present invention significantly suppresses a reduction in a peripheral nerve conduction rate and alleviates the hypofunction of the bladder so that it is useful as a preventive and/or therapeutic agent for diabetes complications, particularly, for diabetic neuropathy.
REFERENCES:
patent: 6906107 (2005-06-01), Miyagawa et al.
patent: 2004/0115810 (2004-06-01), Luu et al.
patent: 2004/0152786 (2004-08-01), Luu et al.
patent: 0 555 149 (1993-08-01), None
patent: WO98/56426 (1998-12-01), None
patent: WO99/08987 (1999-02-01), None
patent: 00 47199 (2000-08-01), None
Tarone et al. “Integrin function and regulation in development.” International Journal of Developmental Biology. 2000. 44. pp. 725-731.
Apfel, SC. “Neurotrophic Factors in the Therapy of Diabetic Neuropathy”. American Journal of Medicine. 1999. vol. 107, No. 2B. pp. 34S-42S.
Chiarelli et al. “Role of Growth Factors in the Development of Diabetic Complications”. Hormone Research. 2000. vol. 53. pp. 53-67.
Hammes et al. “Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes”. Molecular Medicine. 1995. vol. 1, No. 5. pp. 527-534.
Ahmed (Diabetes Research and Clinical Practice 67 (2005) 3-21).
Takano et al (Neuroscience Letters, vol. 275, Issue 3 (1999) pp. 175-178).
Biessels et al (Diabetologia (1994) 37:643-650).
Zhuang et al (Experimental Neurology, vol. 140, Issue 2, (1996) 198-205).
U.S. Appl. No. 10/468,138, filed Aug. 18, 2003, Miyagawa, et al.
Database Biosis ′Online ! Biosciences Information Service, Philadelphia, PA, US; 1998 Unger J W et al: “Nerve growth factor (NGF) and diabetic neuropathy in the rat: Morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord” Database accession No. PREV199800499846 XP002201770 abstract & Experimental Neurology, vol. 153, No. 1, 1998, pp. 23-34, ISSN: 0014-4886.
Database Biosis ′Online ! Biosciences Information Service, Philadelphia, PA. US; 1995 Hammes Hans-Petet et al: “Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes.” Database accession No. PREV199699149925 XP002201771 abstract & Molecular Medicine (Cambridge) vol. 1, No. 5, 1995, pp. 527-534, ISSN:1076-1551.
Database Biosis ′Online! Biosciences Information Service, Philadelphia, PA, US; Aug. 30, 1999 Apfel Stuart C: “Neurotrophic factors in the therapy of diabetic neuropathy.” Database accesion No. PREV199900487598 XP002201772 abstract & American Journal of Medicine, vol. 107, No. 2 Part B, Aug. 30, 1999, pp. 34S-42S, ISSN: 0002-9343.
Database Biosis ′Online! Biosciences Information Service, Phladelphia, PA, US; 1984 Nishida T et al: “Uperoxide Dismutase EC-1.15.1.1 Activity in Diabetic Rat Retina” Database accession No. PREV198580008367 XP002201773 abstract & Japanese Journal of Ophthalmology, vol. 28, No. 4, 1984, pp. 377-382, ISSN: 0021-5155.
K.H. Gabbay N. Eng. J. Med.; vol. 288, pp. 831-836 1973.
U.S. Appl. No. 10/478,477, filed Nov. 21, 2003, Luu et al.
U.S. Appl. No. 10/550,305, filed Sep. 22, 2006, Luu, et al.
Luu Bang
Miyagawa Masao
Saito Motoaki
Suzuki Hiroto
Watanabe Takeshi
Krass Frederick
Meiji Dairies Corporation
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Packard Benjamin
LandOfFree
Use of cyclohexenone derivatives in the manufacture of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cyclohexenone derivatives in the manufacture of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyclohexenone derivatives in the manufacture of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245843